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137* The end of a long-term outbreak with highly transmissible
Burkholderia cenocepacia ST32
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Persons with CF can acquire Burkholderia cepacia complex (Bcc) infection through
patient-to-patient contacts or from the environment. The former way of acquisition
was well documented in the Prague CF centre where infection rate with a single
B. cenocepacia strain ST32 reached over 30% in 1997–2003.
The aim of this study was to compare epidemiological situation in the Centre in
2003 vs. 2010, and to evaluate efﬁcacy of infection control in tackling the spread
of ST32. System of surveillance exploiting typing techniques (RAPD and MLST)
was set up in 2008.
A total of 76 out of 211 patients examined by the end of 2003 (36.0%) were infected
with Bcc; majority of them (78.9%) harboured epidemic strain ST32. Seven years
later, Bcc positivity was detected in 72 out of 374 patients who attended the Prague
CF clinic (19.3%). While 39 patients still suffered from infection with ST32 (54.2%
of infected), a substantial portion of patients carried strains other than ST32 (see
Table; note that ST number is speciﬁed only if more than two patients harboured
the strain). Notably, only 2 patients within the ST32 group became positive after
2003, with the last case dated in May 2007.
Epidemiological situation characterized by increasing heterogeneity of the Bcc
population and no occurrence of new ST32 cases is a likely consequence of both
healthcare workers’ and patients’ good compliance with strict infection control
rules.
Supported by NS10543−3, MSM0021620812 and MZ0FNM2005.
Strain distribution
Bcc species cenocepacia multivorans stabilis contaminans
IIIA IIIB
ST number 32/234/other 184/other other 480/other 102
2003 (No of pts) 60/3/0 2/2 3 1/4 1
2010 (No of pts) 39/7/1 3/1 8 3/5 5
138 Genetic ﬁngerprinting of Stenotrophomonas maltophilia strains
isolated from cystic ﬁbrosis patients
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Aim: Rep-PCR-based DNA ﬁngerprinting was used to compare isolates
Stenotrophomonas maltophilia (Sm) of recovered from CF patients (pts).
Materials and Methods: In 2009, 48 Sm strains were isolated from respiratory
samples of 33 CF pts. DNA ﬁngerprints were obtained from the products of rep-
PCR ampliﬁcation and analyzed using dedicated software to determine strain genetic
relatedness.
Results: The dendrogram showed a strain distribution as follows:
• 21 strains from 18 pts were considered unrelated to each other
• Cluster 1 included 3 different strains (3 pts), similar to each other (92%)
• Cluster 2 and 3 each consisting of 2 strains (2 pts in both) similar to each other
(both 98%)
• Cluster 4 and 5 each consisting of 3 strains (2 pts in both) with a similarity of
93% and 95% respectively
• Cluster 6 composed by 5 strains (3 pts) with a similarity of 94% to each other
From 11 patients, colonized by Sm and followed in 2009, were isolated 26 strains
(3 strains from 4 pts and 7 strains from 2 pts) showing a similarity range of 65−99%.
Furthermore 60% of these 11 pts, showed to have the same strain (similarity range
98−99%).
Conclusions: The use of rep-PCR has allowed us to deﬁne the correlation between
the strains isolated from both the same and different pts. As for the identiﬁed
clusters, we could only note that 48 strains showed no signiﬁcant similarity, thus
excluding a cross-infaction among pts. Therefore the presence of these six clusters
could be justiﬁed by the ubiquitous presence of Sm both in nature and in hospitals.
The high rate of colonization events suggested that a re-infection with the same
strain or no eradication are frequent.
139 Diagnosis of nontuberculous mycobacteria infection in cystic
ﬁbrosis: how to decontaminate respiratory samples?
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Objectives: Nontuberculous mycobacteria (NTM) are potential respiratory
pathogens in CF patients. In this setting, the most widely used decontamination
method preceeding NTM culture, is the N-acetyl-L-cysteine-NaOH-oxalic acid
(REF) method. However, some reports suggest that this method affects the via-
bility of mycobacteria. Recently, a chloorhexidine (CHX) decontamination method
showed to be superior. Our aim was to compare these 2 decontamination methods.
Methods: 795 respiratory samples collected at 4 different centers from 312 CF
patients were divided equally into two aliquots. After REF or CHX decontamination,
they were processed for staining and culture by inoculating 1 Lo¨wenstein-Jensen and
1 Ogawa slant. Samples were scored as contaminated if both slants were overgrown.
Results: Overall, only 3 smears were positive. Smears produced after CHX
decontamination were difﬁcult to interpret. 16 sputa cultures from 9 patients were
found to be NTM positive. The recovered NTM species wereMycobacterium avium-
intracellulare (n = 6), M. abcessus (n = 6), M. chelonae (n = 2), M. gordonae (n = 1),
and M. lentiﬂavum (n = 1). Of the 16 positive sputa, 11 were positive with the CHX
method alone, 1 with the REF method alone and 4 with both methods (P = 0.043).
123 specimens were contaminated after CHX decontamination, whereas 179 were
overgrown after REF treatment (P < 0.001).
Conclusion: This work shows that CHX decontamination is more sensitive than
the REF decontamination for the recovery of NTM from respiratory samples of
CF patients. CHX decontamination yielded a lower contamination rate but smears
produced after CHX decontamination were difﬁcult to interpret.
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Objective: To compare the relative capabilities of automated liquid culture and
solid media for isolation of non-tuberculous mycobacteria (NTM) from CF sputum
samples.
Method: A retrospective analysis of 2,962 CF sputum samples submitted for NTM
culture between July 2004 and December 2009. All samples were cultured using an
automated liquid culture device (MGIT 960) and on solid media (Lowenstein-Jensen
slopes).
Results: NTM were isolated from 287 samples (9.8%). Of these, 282 (98.3%) were
isolated in liquid culture alone, 168 (58.5%) were isolated from both media and
only ﬁve (1.7%) were isolated from solid media alone. None of these ﬁve isolates
resulted in a change to clinical management. The median time to positivity for
liquid culture was 4 days (range 1−39 days) compared with 14 days (range 5−48
days) for solid media. The most common isolates were MycobacteriuM. chelonae
(112; 39%), M. abscessus (86; 30%), M. avium (62; 22%) and M. intracellulare
(21; 7%). The remaining six isolates could not be identiﬁed to species level by the
reference laboratory and were classiﬁed as ‘AAFB’ (2%). There were no mixed
infections identiﬁed during the study period.
Conclusion: Automated liquid culture was superior to solid media for isolation of
NTM from CF sputum samples in terms of isolation rates and time to positivity.
The inclusion of solid media in addition to automated liquid culture provided no
extra value.
